Omeros Corp

9 nov. 2026, 21:07 UTC

Omeros Corporation shares are advancing, recovering from an early dip and reflecting a cumulative gain since Friday's close amid a recent downward trend.

6 nov. 2026, 20:46 UTC

Omeros Corporation shares are lower, retracing from an early gain, amid broader market weakness and three consecutive sessions of losses.

5 nov. 2026, 21:04 UTC

Omeros Corporation shares fell sharply, reaching their lowest point around midday and remaining well below the 20-day moving average.

2 nov. 2026, 21:09 UTC

Omeros Corporation shares fell significantly, reaching their lowest point in early afternoon trading amid notable volatility and remaining within the one-month trading range.

30 oct. 2026, 21:21 UTC

Shares down notably in after-market trading after volatile session.

29 oct. 2026, 20:02 UTC

Omeros Corporation shares are advancing, reflecting strong trading activity with high volume, despite a slight pullback from earlier session highs.

28 oct. 2026, 20:52 UTC

Omeros Corporation shares are trading lower in after-market hours, reflecting a significant decline in the broader market and falling to their lowest level of the day.

27 oct. 2026, 22:56 UTC

Omeros Corporation's shares traded lower in after-market hours, remaining below their 20-day moving average despite a slight recovery from an earlier decline.

23 oct. 2026, 19:36 UTC

Omeros Corp shares are declining, pulling back significantly from an earlier session high and remaining below Thursday's close.

22 oct. 2026, 22:41 UTC

Omeros Corp is trading lower in after-market hours, continuing a downward trend and remaining significantly below Thursday's close and its 20-day moving average.

19 oct. 2026, 20:07 UTC

Omeros Corp shares advanced after the CHMP issued a negative opinion on its narsoplimab marketing authorization application for thrombotic microangiopathy.

16 oct. 2026, 23:51 UTC

Omeros Corp receives a negative opinion from the European Medicines Agency on its narsoplimab marketing authorization application for thrombotic microangiopathy.

15 oct. 2026, 19:31 UTC

Omeros Corp shares are advancing amid a broader Pharmaceuticals sector rally, with unusually high trading volume reflecting increased investor activity.

13 oct. 2026, 20:08 UTC

Omeros Corp shares are declining, reaching their lowest point just before the close amid a broader market trend of significant downward movement.

6 oct. 2026, 20:07 UTC

Omeros Corp shares are declining, reaching their lowest point mid-morning and finishing well below the 20-day moving average amid weaker overall market performance.

5 oct. 2026, 20:06 UTC

Omeros Corp is advancing, reflecting a gain from Friday's close, despite pulling back from an earlier session high.

2 oct. 2026, 21:01 UTC

Omeros Corp is trading lower in after-market hours, continuing a downward trend that has lasted for six consecutive sessions.

1 oct. 2026, 22:15 UTC

Omeros Corp is trading modestly higher in after-market hours following five consecutive sessions of declines, despite mixed signals in the broader market.

30 sept. 2026, 19:46 UTC

Omeros Corp shares fell modestly Wednesday, continuing a decline observed over the past three trading days, despite remaining above the 20-day moving average.

28 sept. 2026, 20:07 UTC

Omeros Corp shares are declining, following a broader market trend, after peaking early in the session and reaching a low before the close.

24 sept. 2026, 19:35 UTC

Omeros Corp shares fell sharply after an earlier gain, despite remaining above the 20-day moving average and near the upper end of its one-month range.

23 sept. 2026, 23:02 UTC

Omeros Corp's stock declined in after-market trading, dropping from Wednesday's close despite remaining above its 20-day moving average.

22 sept. 2026, 20:02 UTC

Omeros shares advance sharply after Cantor Fitzgerald upgraded the stock to Overweight, citing strong Yartemlea launch and reinstating a $22 price target.

21 sept. 2026, 19:16 UTC

Omeros Corp has advanced during Monday's trading session, reaching a notable peak earlier in the day while remaining below its 20-day moving average.

18 sept. 2026, 20:13 UTC

Omeros Corp's shares declined in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

17 sept. 2026, 20:08 UTC

Omeros Corp is advancing sharply in Thursday's trading, having risen as much as 7% earlier before pulling back slightly, reflecting strong overall market gains.

16 sept. 2026, 19:36 UTC

Omeros Corp is trading higher, having peaked earlier in the day, though it remains below its 20-day moving average amid a broader trend of lower closes.

15 sept. 2026, 20:51 UTC

Omeros Corp shares are lower in after-market hours, continuing a five-session decline amid broader market pressures and elevated crude oil prices.

14 sept. 2026, 23:06 UTC

Omeros Corp shares are lower in after-market hours, continuing a trend of declines amid broader market pressure from rising crude oil prices.

10 sept. 2026, 20:03 UTC

Omeros Corp shares are lower today, continuing a decline since Wednesday. Trading volume is notably high, reflecting increased investor activity.